Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Intestinal FXYD12 and sodium-potassium ATPase: A comparative study on two euryhaline medakas in response to salinity changes.

Yang WK, Hsu AD, Kang CK, Lai IP, Liao PS, Lee TH.

PLoS One. 2018 Jul 27;13(7):e0201252. doi: 10.1371/journal.pone.0201252. eCollection 2018.

2.

Different Modulatory Mechanisms of Renal FXYD12 for Na(+)-K(+)-ATPase between Two Closely Related Medakas upon Salinity Challenge.

Yang WK, Kang CK, Hsu AD, Lin CH, Lee TH.

Int J Biol Sci. 2016 Apr 28;12(6):730-45. doi: 10.7150/ijbs.15066. eCollection 2016.

3.

Expression profiles of branchial FXYD proteins in the brackish medaka Oryzias dancena: a potential saltwater fish model for studies of osmoregulation.

Yang WK, Kang CK, Chang CH, Hsu AD, Lee TH, Hwang PP.

PLoS One. 2013;8(1):e55470. doi: 10.1371/journal.pone.0055470. Epub 2013 Jan 31.

4.

Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.

Kwong MS, Chung GG, Horvath LJ, Ward BA, Hsu AD, Carter D, Tavassoli F, Haffty B, Burtness BA.

Cancer J. 2006 May-Jun;12(3):212-21.

PMID:
16803680
5.

Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.

Abu-Khalaf MM, Windsor S, Ebisu K, Salikooti S, Ananthanarayanan G, Chung GG, DiGiovanna MP, Haffty BG, Abrams M, Farber LR, Hsu AD, Reiss M, Zelterman D, Burtness BA.

Oncology. 2005;69(5):372-83. Epub 2005 Nov 24.

PMID:
16319508

Supplemental Content

Support Center